
25I-NBOH: a new potent serotonin 5-HT2A receptor agonist identified in blotter paper seizures in Brazil
2017; Springer Science+Business Media; Volume: 35; Issue: 2 Linguagem: Inglês
10.1007/s11419-017-0357-x
ISSN1860-8973
AutoresLuciano C. Arantes, E. Ferrari, Luciano Figueiredo de Souza, Andriele Costa Cardoso, Thaynara Lino Fernandes Alcântara, Luciano M. Lião, Yuri Machado, Rogério Araújo Lordeiro, José Coelho Neto, Ana Flávia Belchior de Andrade,
Tópico(s)Neurotransmitter Receptor Influence on Behavior
ResumoA new potent serotonin 5-HT2A receptor agonist was identified in blotter papers by several state level forensic laboratories in Brazil. The 25I-NBOH is a labile molecule, which fragments into 2C-I when analyzed by routine seized material screening gas chromatography (GC) methods. GC–mass spectrometry (MS), liquid chromatography–quadrupole time-of-flight-MS, and Fourier transform infrared and nuclear magnetic resonance analyses were performed to complete molecular characterization. Individual doses range from 300 to 1000 μg. Despite its being a potent 5-HT2A receptor agonist, 25I-NBOH is neither registered in the United Nations Office on Drugs and Crime (UNODC) nor classified as a scheduled substance in most countries. Sweden and Brazil seem to be the only countries to control 25I-NBOH. To our knowledge, this is the first scientific report dealing with identification of 25I-NBOH in actual seizures.
Referência(s)